Caspase-10-dependent Cell Death in Fas/CD95 Signalling is Not Abrogated by Caspase Inhibitor ZVAD-fmk

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2010 Nov 5

PMID 21049020

Citations 9

Authors

Elodie Lafont

Delphine Milhas

Justin Teissie

Nicole Therville

Nathalie Andrieu-Abadie

Thierry Levade

Herve Benoist

Bruno Segui

Affiliations

Soon will be listed here.

Abstract

Background: Upon CD95/Fas ligation, the initiator caspase-8 is known to activate effector caspases leading to apoptosis. In the presence of zVAD-fmk, a broad-spectrum caspase inhibitor, Fas engagement can also trigger an alternative, non-apoptotic caspase-independent form of cell death, which is initiated by RIP1. Controversy exists as to the ability of caspase-10 to mediate cell death in response to FasL (CD95L or CD178). Herein, the role of caspase-10 in FasL-induced cell death has been re-evaluated.

Methodology And Principal Findings: The present study shows that FasL-induced cell death was completely impaired in caspase-8- and caspase-10-doubly deficient (I9-2e) Jurkat leukaemia T-cell lines. Over-expressing of either caspase-8 or caspase-10 in I9-2e cells triggered cell death and restored sensitivity to FasL, further arguing for a role of both initiator caspases in Fas apoptotic signalling. In the presence of zVAD-fmk, FasL triggered an alternative form of cell death similarly in wild-type (A3) and in caspase-8-deficient Jurkat cells expressing endogenous caspase-10 (clone I9-2d). Cell death initiated by Fas stimulation in the presence of zVAD-fmk was abrogated in I9-2e cells as well as in HeLa cells, which did not express endogenous caspase-10, indicating that caspase-10 somewhat participates in this alternative form of cell death. Noteworthy, ectopic expression of caspase-10 in I9-2e and HeLa cells restored the ability of FasL to trigger cell death in the presence of zVAD-fmk. As a matter of fact, FasL-triggered caspase-10 processing still occurred in the presence of zVAD-fmk.

Conclusions And Significance: Altogether, these data provide genetic evidence for the involvement of initiator caspase-10 in FasL-induced cell death and indicate that zVAD-fmk does not abrogate caspase-10 processing and cytotoxicity in Fas signalling. Our study also questions the existence of an alternative caspase-independent cell death pathway in Fas signalling.

Citing Articles

Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases.

Risso V, Lafont E, Le Gallo M Cell Death Dis. 2022; 13(3):248.

PMID: 35301281 PMC: 8931059. DOI: 10.1038/s41419-022-04688-x.

Loss of FADD and Caspases Affects the Response of T-Cell Leukemia Jurkat Cells to Anti-Cancer Drugs.

Mrkvova Z, Portesova M, Slaninova I Int J Mol Sci. 2021; 22(5).

PMID: 33800107 PMC: 7962194. DOI: 10.3390/ijms22052702.

Proteome-wide covalent ligand discovery in native biological systems.

Backus K, Correia B, Lum K, Forli S, Horning B, Gonzalez-Paez G Nature. 2016; 534(7608):570-4.

PMID: 27309814 PMC: 4919207. DOI: 10.1038/nature18002.

iPSC-Based Models to Unravel Key Pathogenetic Processes Underlying Motor Neuron Disease Development.

Faravelli I, Frattini E, Ramirez A, Stuppia G, Nizzardo M, Corti S J Clin Med. 2015; 3(4):1124-45.

PMID: 26237595 PMC: 4470174. DOI: 10.3390/jcm3041124.

Caspase functions in cell death and disease.

McIlwain D, Berger T, Mak T Cold Spring Harb Perspect Biol. 2013; 5(4):a008656.

PMID: 23545416 PMC: 3683896. DOI: 10.1101/cshperspect.a008656.

References

Boone E, Vanden Berghe T, van Loo G, De Wilde G, De Wael N, Vercammen D . Structure/Function analysis of p55 tumor necrosis factor receptor and fas-associated death domain. Effect on necrosis in L929sA cells. J Biol Chem. 2000; 275(48):37596-603. DOI: 10.1074/jbc.M007166200. View

Morgan M, Thorburn J, Thomas L, Maxwell T, Brothman A, Thorburn A . An apoptosis signaling pathway induced by the death domain of FADD selectively kills normal but not cancerous prostate epithelial cells. Cell Death Differ. 2001; 8(7):696-705. DOI: 10.1038/sj.cdd.4400866. View

Matsumura H, Shimizu Y, Ohsawa Y, Kawahara A, Uchiyama Y, Nagata S . Necrotic death pathway in Fas receptor signaling. J Cell Biol. 2000; 151(6):1247-56. PMC: 2190580. DOI: 10.1083/jcb.151.6.1247. View

Juo P, Kuo C, Yuan J, Blenis J . Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. Curr Biol. 1998; 8(18):1001-8. DOI: 10.1016/s0960-9822(07)00420-4. View

Fischer U, Stroh C, Schulze-Osthoff K . Unique and overlapping substrate specificities of caspase-8 and caspase-10. Oncogene. 2005; 25(1):152-9. DOI: 10.1038/sj.onc.1209015. View

Muzio M, Chinnaiyan A, Kischkel F, ORourke K, Shevchenko A, Ni J . FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex. Cell. 1996; 85(6):817-27. DOI: 10.1016/s0092-8674(00)81266-0. View

Kawahara A, Ohsawa Y, Matsumura H, Uchiyama Y, Nagata S . Caspase-independent cell killing by Fas-associated protein with death domain. J Cell Biol. 1998; 143(5):1353-60. PMC: 2133085. DOI: 10.1083/jcb.143.5.1353. View

Wang H, Wang P, Sun X, Luo Y, Wang X, Ma D . Cloning and characterization of a novel caspase-10 isoform that activates NF-kappa B activity. Biochim Biophys Acta. 2007; 1770(11):1528-37. DOI: 10.1016/j.bbagen.2007.07.010. View

Wang J, Chun H, Wong W, Spencer D, Lenardo M . Caspase-10 is an initiator caspase in death receptor signaling. Proc Natl Acad Sci U S A. 2001; 98(24):13884-8. PMC: 61136. DOI: 10.1073/pnas.241358198. View

10.

Fernandes-Alnemri T, Armstrong R, Krebs J, Srinivasula S, Wang L, Bullrich F . In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci U S A. 1996; 93(15):7464-9. PMC: 38767. DOI: 10.1073/pnas.93.15.7464. View

11.

Shimizu M, Fontana A, Takeda Y, Yagita H, Yoshimoto T, Matsuzawa A . Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells. J Immunol. 1999; 162(12):7350-7. View

12.

Cohen G . Caspases: the executioners of apoptosis. Biochem J. 1997; 326 ( Pt 1):1-16. PMC: 1218630. DOI: 10.1042/bj3260001. View

13.

Luo X, Budihardjo I, Zou H, Slaughter C, Wang X . Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 1998; 94(4):481-90. DOI: 10.1016/s0092-8674(00)81589-5. View

14.

Milhas D, Cuvillier O, Therville N, Clave P, Thomsen M, Levade T . Caspase-10 triggers Bid cleavage and caspase cascade activation in FasL-induced apoptosis. J Biol Chem. 2005; 280(20):19836-42. DOI: 10.1074/jbc.M414358200. View

15.

Lenardo M . Molecular regulation of T lymphocyte homeostasis in the healthy and diseased immune system. Immunol Res. 2003; 27(2-3):387-98. DOI: 10.1385/IR:27:2-3:387. View

16.

Siegel R, Martin D, Zheng L, Ng S, Bertin J, Cohen J . Death-effector filaments: novel cytoplasmic structures that recruit caspases and trigger apoptosis. J Cell Biol. 1998; 141(5):1243-53. PMC: 2137190. DOI: 10.1083/jcb.141.5.1243. View

17.

Gabriel B, Sureau F, Casselyn M, Teissie J, Petit P . Retroactive pathway involving mitochondria in electroloaded cytochrome c-induced apoptosis. Protective properties of Bcl-2 and Bcl-XL. Exp Cell Res. 2003; 289(2):195-210. DOI: 10.1016/s0014-4827(03)00255-6. View

18.

Worth A, Thrasher A, Gaspar H . Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype. Br J Haematol. 2006; 133(2):124-40. DOI: 10.1111/j.1365-2141.2006.05993.x. View

19.

Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S . Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol. 2001; 1(6):489-95. DOI: 10.1038/82732. View

20.

Cuvillier O, Edsall L, Spiegel S . Involvement of sphingosine in mitochondria-dependent Fas-induced apoptosis of type II Jurkat T cells. J Biol Chem. 2000; 275(21):15691-700. DOI: 10.1074/jbc.M000280200. View